The tragic case of Oliver Robinson, who took his own life in November 2023, has ignited a significant debate around the regulation of private cannabis clinics in the UK. An inquest into his death revealed that his prescription for medicinal cannabis had likely played a detrimental role in his mental health, prompting calls from his family for stricter safeguards to protect vulnerable individuals from inadequate care.
The Inquest Findings
Oliver Robinson, 34, had been battling severe depression and addiction for several years. His journey through mental health treatment included multiple admissions to the Priory, a private facility, where he sought help from 2019 to 2022. After feeling that traditional therapies had failed him, he turned to Curaleaf Clinic, a private cannabis provider, in May 2022. His family now believes that this decision contributed to his worsening condition.
During the inquest, Catherine McKenna, the coroner for Manchester North, concluded that Robinson’s cannabis prescription acted as an “obstacle” to receiving the appropriate psychiatric and addiction care he desperately needed. This ruling marks a pivotal moment, as it is reportedly the first instance of its kind in the UK, highlighting the potential risks associated with unregulated cannabis prescriptions.
A Call for Reform
Following the inquest, Oliver’s brother, Alexander Robinson, has launched a campaign aimed at reforming the regulations governing private cannabis clinics. He is advocating for a ban on prescribing cannabis to individuals with serious mental illnesses and is calling for improved oversight of the burgeoning industry. “If things do not change, he is not going to be the last,” Alexander stated, underscoring his concern for others who might find themselves in similar situations.
Medicinal cannabis was legalised in the UK in 2018, primarily to provide relief for patients with severe conditions. However, the NHS remains cautious, typically prescribing only a limited number of licensed cannabis-based products for conditions such as epilepsy and chronic pain. In contrast, private clinics often dispense unlicensed products, which have not undergone rigorous evaluation by health authorities. According to the Care Quality Commission (CQC), an alarming number of these prescriptions—over 659,000—were issued privately in 2024.
The Mental Health Implications
Experts have raised serious concerns regarding the efficacy of cannabis as a treatment for mental health disorders. Dr Pavan Chahl, a psychiatrist who testified at Robinson’s inquest, pointed out that current guidelines advise against prescribing medicinal cannabis to patients with a history of severe psychiatric disorders. “There is a lack of evidence for efficacy in depression and evidence it can cause or worsen depression,” he stated, adding that Oliver should never have been prescribed cannabis.
The growing number of private prescriptions, compounded by the limited evidence supporting cannabis as a treatment for depression, presents a concerning picture. Alexander Robinson has proposed what he calls “Oliver’s Law,” which includes mandatory consultations with NHS mental health teams before prescribing, face-to-face assessments for complex cases, and routine audits of private clinics.
The Tragic Downward Spiral
Oliver’s struggles with mental health were profound and complex. Once a successful property developer, he faced significant challenges following the collapse of his business and a personal relationship, leading to depression and two inpatient admissions. Despite a history of cannabis use since his teenage years, his family believed that his medicinal cannabis prescription would provide relief. However, the reality proved to be quite different.
As his mental health deteriorated, family members noticed alarming changes in his behaviour. Reports of violent outbursts and erratic conduct became common, leading to police involvement and a restraining order against him. Communication with his family became strained and fragmented, with Oliver increasingly isolating himself. The final months of his life were marked by significant distress, culminating in a heartbreaking call from a friend indicating that he intended to take his life.
Why it Matters
The loss of Oliver Robinson serves as a sobering reminder of the urgent need for enhanced regulatory measures surrounding private cannabis clinics in the UK. His family’s campaign highlights critical gaps in the current system, particularly concerning the prescribing of cannabis to individuals with complex mental health issues. As the debate continues, it is imperative for health authorities to reassess the framework governing medicinal cannabis to ensure that vulnerable patients receive safe and effective care. The implications of this case could reshape the landscape of mental health treatment, potentially preventing future tragedies.
